Sector: MedicalABIOMED, Inc. (NASDAQ: ABMD)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 221 |
Technical : | 84 |
Performance : | 20 |
Overall: | 77 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 195 |
Technical : | 162 |
Performance : | 13 |
Overall: | 105 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 200 |
Technical : | 23 |
Performance : | 9 |
Overall: | 24 |
Number of Stocks: | 306 |
Headlines
- Amarin Appoints John F. Thero as Chief Financial Officer
Nov 06, 2009 04:15 AM | ABMD, AMRN
- Abiomed Announces Record Revenue of $20 Million for Second Quarter of Fiscal 2010
Nov 05, 2009 07:00 AM | ABMD
- Abiomed Second Fiscal Quarter 2010 Earnings and Conference Call Notification
Oct 28, 2009 09:01 AM | ABMD
- Abiomed Reports Results from Academic Medical Center's Three-Year Follow-up of MACH II Trial
Sep 23, 2009 09:14 AM | ABMD
- Abiomed to Present at Morgan Stanley 2009 Global Healthcare Unplugged Conference
Sep 10, 2009 10:08 AM | ABMD, MS
- Abiomed to Showcase Impella(R) Technology at TCT 2009; Customer Evening Symposium on Tuesday, September 22
Sep 08, 2009 11:25 AM | ABMD
- First Post-Trial AbioCor Patient Passes Away
Sep 01, 2009 04:00 PM | ABMD
- Stem Cell & Regenerative Medicine Stocks Surge in Past Month
Dec 19, 2008 08:08 PM | ABMD, AGE, ATSI, CRM, CYTX, EW
- Nine Stocks To Watch, Potential Breakouts, No Pump & Dumps, Sad Day
Jul 28, 2008 12:38 PM | ABMD, ATSI, DTLK, USS, VISN
- Kinetic Concepts and LifeCell Agree Amicably to $1.7 Billion Buyout Deal
Apr 07, 2008 04:42 PM | ABMD, KCI, LIFC
- Webcast Now Available: Successful Abiomed Impella® 2.5 High-Risk PCI Procedure at Mount Sinai Medical Center
Aug 11, 2009 10:10 AM | ABMD
- Abiomed Announces Fiscal First Quarter Revenue of $19.9 Million and Record Impella® Revenue up 107% to $12 Million
Aug 06, 2009 07:07 AM | ABMD
- Abiomed First Fiscal Quarter 2010 Earnings and Conference Call Notification
Jul 28, 2009 08:09 AM | ABMD
- Abiomed Announces First FDA-Approved AbioCor® Implant at UMDNJ-Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital
Jun 24, 2009 10:01 AM | ABMD
- Abiomed Announces Fiscal Fourth Quarter Revenue of $19.6 Million and Record Impella Revenue Up 124% to $11.2 Million
May 12, 2009 07:52 AM | ABMD
- Abiomed to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
May 06, 2009 09:35 AM | ABMD
- FDA Approves Abiomed’s New AB Portable™ Driver; Providing Patient Transport, Mobility and Ambulation without Compromising Performance
Mar 30, 2009 08:29 AM | ABMD
- Abiomed to Showcase Impella® Heart Recovery Platform at American College of Cardiology Annual 2009 Meeting
Mar 26, 2009 12:25 PM | ABMD
- Journal of the American College of Cardiology Publishes PROTECT I Study Results for Abiomed Impella 2.5
Mar 11, 2009 10:09 AM | ABMD
- Abiomed Appoints Michael Howley as Vice President and General Manager of Global Sales and Marketing
Mar 05, 2009 11:35 AM | ABMD
- Form 4 Bowen Robert For: Sep 30 (10K)
Oct 02, 2009 05:41 PM
- Form 4 MINOGUE MICHAEL R For: Sep 30 (10K)
Oct 02, 2009 05:40 PM
- Form 4 BOLT WILLIAM J For: Sep 30 (10K)
Oct 02, 2009 05:39 PM
- Form 4 ABIOMED INC For: Aug 12 Filed by: ROSE ERIC A MD (10K)
Aug 14, 2009 07:20 PM
- Form 4 LATAIF LOUIS E For: Aug 12 (10K)
Aug 14, 2009 07:20 PM
- Form 4 AUSTEN W GERALD For: Aug 12 (10K)
Aug 14, 2009 07:16 PM
- Form 4 ABIOMED INC For: Aug 12 Filed by: SUTTER MARTIN P (10K)
Aug 14, 2009 07:16 PM
- Form 4 PUHY DOROTHY E For: Aug 12 (10K)
Aug 14, 2009 07:06 PM
- Form 4 ABIOMED INC For: Aug 12 Filed by: TERMEER HENRI A (10K)
Aug 14, 2009 07:05 PM
- Form 4 Bowen Robert For: Aug 12 (10K)
Aug 14, 2009 05:48 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ABMD
|
Compare to S&P
|
| YTD |
-45.86 %
|
-55.28 %
|
| 4 Weeks |
-18.44 %
|
-18.87 %
|
| 12 Weeks |
9.08 %
|
2.36 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -5.00 %
|
|
EPS Growth in Last Year: -16.67 %
|
|
Sales Growth in Last Quarter: 0.55 %
|
|
Sales Growth in Last Quarter: 0.11 %
|
|
